Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000

Mortality due to coronary heart disease has declined substantially in the United States in recent decades. A previously validated model was used to estimate the roles of specific cardiac treatments and changes in risk factors in this decline. Approximately 47% of the decrease in mortality was attrib...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 356; no. 23; pp. 2388 - 2398
Main Authors Ford, Earl S, Ajani, Umed A, Croft, Janet B, Critchley, Julia A, Labarthe, Darwin R, Kottke, Thomas E, Giles, Wayne H, Capewell, Simon
Format Journal Article
LanguageEnglish
Published Boston, MA Massachusetts Medical Society 07.06.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mortality due to coronary heart disease has declined substantially in the United States in recent decades. A previously validated model was used to estimate the roles of specific cardiac treatments and changes in risk factors in this decline. Approximately 47% of the decrease in mortality was attributed to therapeutic interventions and 44% to changes in risk factors. Mortality due to coronary heart disease has declined substantially in the United States in recent decades. Approximately 47% of the decrease in mortality was attributed to therapeutic interventions and 44% to changes in risk factors. Rates of death from coronary heart disease in the United States underwent profound secular changes during the 20th century. 1 , 2 After peaking around 1968, age-adjusted rates were cut in half. Two factors may have contributed to this decline. First, there have been substantial decreases in the prevalence of some major cardiovascular risk factors, including smoking, elevated total cholesterol, and high blood pressure. 3 – 8 However, the prevalence of both obesity and diabetes has increased alarmingly. 9 – 11 Second, there has been a revolution in the treatments for established coronary heart disease, with major breakthroughs in evidence-based therapies, including the use of thrombolysis, . . .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMsa053935